Insulin Resistance in Type I Diabetes in Pediatric Care
NCT ID: NCT00946426
Last Updated: 2015-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2009-07-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Defining the Role of Management Factors in Outcome Disparity in Pediatric T1D
NCT04614623
Risk Factors of Metabolic Control in Children and Adolescents With Type 1 Diabetes
NCT03642470
Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
NCT00357890
Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes
NCT02548494
Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes
NCT04696640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic
Hyperinsulinemic euglycemic clamp
Clamp
Insulin sensitivity, Hepatic glucose production, Evaluation of inflammation, Socioeconomic status, Ethnicity and family history
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clamp
Insulin sensitivity, Hepatic glucose production, Evaluation of inflammation, Socioeconomic status, Ethnicity and family history
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ages 9 -11 tanner 1 or 16-23 tanner 4-5
Exclusion Criteria
9 Years
23 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nationwide Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Research Institute at Nationwide Children's Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dana S Hardin, MD
Role: PRINCIPAL_INVESTIGATOR
The Research Institute at Nationwide Children's Hospital, The Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nationwide Children's Hospital
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB09-00160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.